Search
User Avatar Login
The Defender
  • Explore The Defender
  • Categories
    • CHD.TV
  • Explore CHD.TV
  • Archive
    • Resources
  • Explore Our Resources
  • CHD Bookstore
  • CHD Films
  • eBooks
    • Community
  • Explore Advocacy
  • Community
  • Advocacy Help
    • Science
  • Explore the Science Section
  • Science Library
  • Vaccines
  • Electromagnetic Radiation
    • Legal Justice
  • Explore Litigation
  • Learn The Law
    • About Us
  • About Children’s Health Defense
  • More from CHD
    • Vax-Unvax: Let The Science Speak Home › Citations

    Chapter 9

    This is a listing of all citations in this chapter.

    1

    “Hepatitis B Vaccination of Infants, Children, and Adolescents,” U.S. Centers for Disease Control, accessed March 26, 2023.

    2

    Monica A. Fisher and Stephen A. Eklund, “Hepatitis B Vaccine and Liver Problems in U.S. Children Less than 6 Years Old, 1993 and 1994,” Epidemiology 10, no. 3 (1999): 337–339.

    3

    Monica A. Fisher and Stephen A. Eklund, “Hepatitis B Vaccine and Liver Problems in U.S. Children Less than 6 Years Old, 1993 and 1994,” Epidemiology 10, no. 3 (1999): 337–339.

    4

    Monica A. Fisher and Stephen A. Eklund, “Hepatitis B Vaccine and Liver Problems in U.S. Children Less than 6 Years Old, 1993 and 1994,” Epidemiology 10, no. 3 (1999): 337–339.

    5

    Monica A. Fisher and Stephen A. Eklund, “Hepatitis B Vaccine and Liver Problems in U.S. Children Less than 6 Years Old, 1993 and 1994,” Epidemiology 10, no. 3 (1999): 337–339.

    6

    Nancy Agmon-Levin et al., “Immunization with Hepatitis B Vaccine Accelerates SLE-Like Disease in a Murine Model,” Journal of Autoimmunity 54, (2014): 21–32, doi:10.1016/j.jaut.2014.06.006.

    7

    Nancy Agmon-Levin et al., “Immunization with Hepatitis B Vaccine Accelerates SLE-Like Disease in a Murine Model,” Journal of Autoimmunity 54, (2014): 21–32, doi:10.1016/j.jaut.2014.06.006.

    8

    Nancy Agmon-Levin et al., “Immunization with Hepatitis B Vaccine Accelerates SLE-Like Disease in a Murine Model,” Journal of Autoimmunity 54, (2014): 21–32, doi:10.1016/j.jaut.2014.06.006.

    9

    David C. Classen and John Barthelow Classen, “The Timing of Pediatric Immunization and the Risk of Insulin-Dependent Diabetes Mellitus,” Infectious Diseases in Clinical Practice 6, no. 7 (1997): 449-454.

    10

    David C. Classen and John Barthelow Classen, “The Timing of Pediatric Immunization and the Risk of Insulin-Dependent Diabetes Mellitus,” Infectious Diseases in Clinical Practice 6, no. 7 (1997): 449-454.

    11

    David C. Classen and John Barthelow Classen, “The Timing of Pediatric Immunization and the Risk of Insulin-Dependent Diabetes Mellitus,” Infectious Diseases in Clinical Practice 6, no. 7 (1997): 449-454.

    12

    Miguel A Hernán et al., “Recombinant Hepatitis B Vaccine and the Risk of Multiple Sclerosis: A Prospective Study,” Neurology 63, no. 5 (2004): 838–842, doi:10.1212/01.wnl.0000138433.61870.82.

    13

    Miguel A Hernán et al., “Recombinant Hepatitis B Vaccine and the Risk of Multiple Sclerosis: A Prospective Study,” Neurology 63, no. 5 (2004): 838–842, doi:10.1212/01.wnl.0000138433.61870.82.

    14

    Miguel A Hernán et al., “Recombinant Hepatitis B Vaccine and the Risk of Multiple Sclerosis: A Prospective Study,” Neurology 63, no. 5 (2004): 838–842, doi:10.1212/01.wnl.0000138433.61870.82.

    15

    Dong Keon Yon et al., “Hepatitis B Immunogenicity After a Primary Vaccination Course Associated with Childhood Asthma, Allergic Rhinitis, and Allergen Sensitization.” Pediatric Allergy and Immunology: Official Publication of the European Society of Pediatric Allergy and Immunology 29, no. 2 (2018): 221–224, doi:10.1111/pai.12850.

    16

    Dong Keon Yon et al., “Hepatitis B Immunogenicity After a Primary Vaccination Course Associated with Childhood Asthma, Allergic Rhinitis, and Allergen Sensitization.” Pediatric Allergy and Immunology: Official Publication of the European Society of Pediatric Allergy and Immunology 29, no. 2 (2018): 221–224, doi:10.1111/pai.12850.

    17

    Dong Keon Yon et al., “Hepatitis B Immunogenicity After a Primary Vaccination Course Associated with Childhood Asthma, Allergic Rhinitis, and Allergen Sensitization.” Pediatric Allergy and Immunology: Official Publication of the European Society of Pediatric Allergy and Immunology 29, no. 2 (2018): 221–224, doi:10.1111/pai.12850.

    18

    Dong Keon Yon et al., “Hepatitis B Immunogenicity After a Primary Vaccination Course Associated with Childhood Asthma, Allergic Rhinitis, and Allergen Sensitization.” Pediatric Allergy and Immunology: Official Publication of the European Society of Pediatric Allergy and Immunology 29, no. 2 (2018): 221–224, doi:10.1111/pai.12850.

    19

    “VAERS Data,” VAERS, accessed September 23, 2022.

    20

    “VAERS Data,” VAERS, accessed September 23, 2022.

    21

    Penina Haber et al., “Safety of Currently Licensed Hepatitis B Surface Antigen Vaccines in the United States, Vaccine Adverse Event Reporting System (VAERS), 2005–2015,” Vaccine 36, no. 4 (2018): 559-564, doi:10.1016/j.vaccine.2017.11.079.

    22

    Penina Haber et al., “Safety of Currently Licensed Hepatitis B Surface Antigen Vaccines in the United States, Vaccine Adverse Event Reporting System (VAERS), 2005–2015,” Vaccine 36, no. 4 (2018): 559-564, doi:10.1016/j.vaccine.2017.11.079.

    23

    Penina Haber et al., “Safety of Currently Licensed Hepatitis B Surface Antigen Vaccines in the United States, Vaccine Adverse Event Reporting System (VAERS), 2005–2015,” Vaccine 36, no. 4 (2018): 559-564, doi:10.1016/j.vaccine.2017.11.079.

    24

    Penina Haber et al., “Safety of Currently Licensed Hepatitis B Surface Antigen Vaccines in the United States, Vaccine Adverse Event Reporting System (VAERS), 2005–2015,” Vaccine 36, no. 4 (2018): 559-564, doi:10.1016/j.vaccine.2017.11.079.

    25

    Young June Choe et al., “Sudden Death in the First 2 Years of Life Following Immunization in the Republic of Korea,” Pediatrics international: Official Journal of the Japan Pediatric Society 54, no.6 (2012): 905–910, doi:10.1111/j.1442-200X.2012.03697.

    26

    Monica A. Fisher and Stephen A. Eklund, “Hepatitis B Vaccine and Liver Problems in U.S. Children Less than 6 Years Old, 1993 and 1994,” Epidemiology 10, no. 3 (1999): 337–339.

    27

    Nancy Agmon-Levin et al., “Immunization with Hepatitis B Vaccine Accelerates SLE-Like Disease in a Murine Model,” Journal of Autoimmunity 54, (2014): 21–32, doi:10.1016/j.jaut.2014.06.006.

    28

    David C. Classen and John Barthelow Classen, “The Timing of Pediatric Immunization and the Risk of Insulin-Dependent Diabetes Mellitus,” Infectious Diseases in Clinical Practice 6, no. 7 (1997): 449-454.

    29

    Miguel A Hernán et al., “Recombinant Hepatitis B Vaccine and the Risk of Multiple Sclerosis: A Prospective Study,” Neurology 63, no. 5 (2004): 838–842, doi:10.1212/01.wnl.0000138433.61870.82.

    30

    Dong Keon Yon et al., “Hepatitis B Immunogenicity After a Primary Vaccination Course Associated with Childhood Asthma, Allergic Rhinitis, and Allergen Sensitization.” Pediatric Allergy and Immunology: Official Publication of the European Society of Pediatric Allergy and Immunology 29, no. 2 (2018): 221–224, doi:10.1111/pai.12850.